Article Information
History
- February 19, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Robert L. Hollis1,#,
- Ian Croy1,
- Mike Churchman1,
- Clare Bartos1,
- Tzyvia Rye1,
- Charlie Gourley1 and
- C. Simon Herrington1
- 1The Nicola Murray Centre for Ovarian Cancer Research, CRUK Edinburgh Centre, MRC Institute of Genetics and Cancer, University of Edinburgh, Scotland, UK
- ↵#Correspondence: Dr Robb Hollis, Cancer Research UK Edinburgh Centre, MRC Institute of Genetics and Cancer, University of Edinburgh, Crewe Road South, Edinburgh, EH4 2XU, Scotland, UK. robb.hollis{at}ed.ac.uk;
Author contributions RLH: conceptualisation, formal analysis, investigation, methodology, visualisation, funding acquisition, writing – original draft. IC: investigation, writing – review and editing. MC: data curation, project administration, writing – review and editing. TR: data curation, investigation, writing – review and editing. CB: data curation, writing – review and editing. CG: supervision, resources, writing – review and editing CSH: investigation, methodology, supervision, writing – review and editing.
Posted February 19, 2022.
Ovarian carcinosarcoma is a distinct form of ovarian cancer with poorer survival compared to tubo-ovarian high grade serous carcinoma
